SoylentNews is people
SoylentNews is powered by your submissions, so send in your scoop. Only 15 submissions in the queue.
SoylentNews
Submitted via IRC for SoyCow1984
Drug companies are sitting on generics—43% of recently approved aren't for sale
Of the more than 1,600 generic drugs approved by the Food and Drug Administration since January of 2017, more than 700—or 43 percent—are not for sale in the US, according to a new analysis by Kaiser Health News.
The finding means that many pricy, brand-name drugs are not facing the competition that could help drive down soaring prices. Among the drugs missing in action are generic versions of the expensive blood thinner Brilinta and the HIV medication Truvada. Moreover, of the approved drugs that would offer a brand-name drug its first competition, 36 percent are being held off the market, the analysis found.
This discussion has been archived.
No new comments can be posted.
Drug Companies are Sitting on Generics—43% of Recently Approved Aren’t for Sale
|
Log In/Create an Account
| Top
| 48 comments
| Search Discussion
The Fine Print: The following comments are owned by whoever posted them. We are not responsible for them in any way.
You have many friends and very few living enemies.
(Score: 2) by Azuma Hazuki on Tuesday February 12 2019, @01:46AM (1 child)
Like so many other things, this is a problem of political will, not technology. Yes, you can build any number of guillotines; how do you get the guilty parties under the blade?
I am "that girl" your mother warned you about...
(Score: 2) by Thexalon on Tuesday February 12 2019, @02:26AM
There are thousands of us for every 1 of them, numbers will eventually tell.
"Think of how stupid the average person is. Then realize half of 'em are stupider than that." - George Carlin